Is WRBY a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Store rollout and market density, with revenue (ttm) at ~$912M. The bear case rests on valuation is the first risk: with about $7.7 million of trailing net income, the trailing P/E is above 400x and the forward P/E near 39x, so the stock prices in years of execution and leaves little room for a soft quarter. Analysts covering it are spread from $25.00 to $35.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Valuation is the first risk: with about $7.7 million of trailing net income, the trailing P/E is above 400x and the forward P/E near 39x, so the stock prices in years of execution and leaves little room for a soft quarter. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $25.00, +2.9% from the $24.30 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Store rollout and market density. Warby Parker ended Q1 2026 with ~337 stores after ~14 net openings in the quarter, and guided to roughly 50 new stores in 2026. The most optimistic analyst target on WRBY is $35.00, +44.0% from the $24.30 price. That figure is only reachable if this thesis works close to its best case.

Valuation is the first risk: with about $7.7 million of trailing net income, the trailing P/E is above 400x and the forward P/E near 39x, so the stock prices in years of execution and leaves little room for a soft quarter. The AI glasses launch is unproven, and pricing and launch dates were still not firm as of October 2026, so a delayed or poorly received product removes the main reason the multiple is elevated. Competition in smart glasses is intensifying, with Meta and EssilorLuxottica already selling and Samsung launching its own frames. Gross margin compression from promotional activity and the retail mix shift is already visible and could persist, and consensus for Q3 2026 EPS (about $0.09) is below the year-earlier $0.12. Active customer growth has been slowing, which puts more weight on price and attachment rate than on new-customer acquisition. The category is dominated by far larger and better-capitalized players, with EssilorLuxottica, Costco, National Vision and Visionworks together holding the overwhelming majority of U.S. eyewear retail, and eyewear discretionary spending is sensitive to consumer weakness and to tariffs on imported frames. The most pessimistic published target is $25.00, +2.9% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Warby Parker designs and sells its own prescription glasses, sunglasses and contact lenses, and has expanded from direct-to-consumer origins into several hundred physical stores with in-house eye exams.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Store rollout and market density) stalling in the reported numbers rather than in the narrative, the risk above (valuation is the first risk: with about $7.7 million of trailing net income, the trailing P/E is above 400x and the forward P/E near 39x, so the stock prices in years of execution and leaves little room for a soft quarter) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Prescription eyeglasses, sunglasses and contact lenses, plus eye exams and vision tests delivered in its stores by employed optometrists. Glasses start around $95 including single-vision lenses, with progressive lenses and lens add-ons priced higher. The company designs its frames in-house and sells them directly rather than through wholesale distributors.

It became profitable on a GAAP basis for the first time in 2025 and has stayed profitable in 2026, with ~$3.2 million of net income in Q1 and ~$4.6 million in Q2. Trailing twelve-month net income was about $7.7 million as of October 2026, while trailing operating margin was still slightly negative. Analysts expect about $0.42 of EPS for 2026. Profitability is real but thin relative to the roughly $3.0 billion market value.

Google committed up to ~$150 million, structured as ~$75 million toward product development and ~$75 million in equity tied to collaboration milestones. Warby Parker is Google's first eyewear partner on Android XR, and the roadmap includes audio-only frames that talk to Gemini plus versions with an in-lens display for navigation and translation. An intelligent eyewear launch has been signaled for late 2026, without confirmed pricing as of October 2026.